Plenary 1
|
Plenary 2
|
Plenary 3
|
Plenary 4
|
Plenary 5
|
What can we Learn from the Latest Science? |
Improving Care for People with Dementia |
The Impact of New Technology: Should you be Informed of your Risk of Developing Alzheimer's Disease |
Risk Factors and Prevention of Dementia |
Public Policy: The Power of Advocacy and Alzheimer Plans |
Current and Future Treatments
Steve DeKosky
(USA) |
New 10/66 Data on Long-Term Care in Lower and Middle Income Countries
Peter Lloyd-Sherlock
(UK) |
With new imaging techniques it is now possible to identify changes in the brain before symptoms occur. Is it ethical to provide an early diagnosis to those who do not show clinical symptoms? |
Longitudinal Studies of Familial and Sporadic Alzheimer's Disease Provide Strategies for Preclinical Intervention Trials
Colin L Masters (Australia) |
The Power of People with Dementia in Advocacy
Julio Solier
(Puerto Rico) |
New Findings From the 10/66 and EFIGA Study in Puerto Rico
Ivonne Z Jimez (Puerto Rico) |
New Technologies to Improve Dementia Home Care
Mary Sano
(USA) |
Serge Gauthier (Canada)
Helen Chiu
(Hong Kong) |
An Overview of European Prevention Studies
Laura Fratiglioni
(Sweden) |
Role of Law Makers in Dementia Policy
Congressman Michael Urtecho Medina
(Peru) |
Alzheimer's Disease or Cerebral Diabetes
Jose A. Luschinger
(USA) |
Case Management in Dementia
Noriyo Washizu (Japan) |
Jason Karlawish (USA)
Person with dementia
Family Carer |
Identifying Risk Factors of Dementia in Puerto Rico
Heriberto Acosta
(Puerto Rico) |
Prime Minister's Dementia Challenge
Jeremy Hughes (UK)
Gill Ayling
(UK) |